Difficulty: Medium
Average Score: 79%
Practice
Which antiemetic selectively blocks levodopa-induced vomiting without blocking its antiparkinsonian action?
Correct answer
C
Rationale
Rationale:
1. Domperidone selectively blocks levodopa-induced vomiting by acting on peripheral dopamine receptors in the chemoreceptor trigger zone.
2. It does not cross the blood-brain barrier, hence does not interfere with levodopa's antiparkinsonian action.
3. Metoclopramide (A) can cross the blood-brain barrier and may diminish the therapeutic effects of levodopa.
4. Cisapride (B) is a prokinetic agent and does not have a specific antiemetic effect on levodopa-induced vomiting.
5. Ondansetron (D) is a serotonin receptor antagonist that targets different pathways and does not specifically address levodopa-induced vomiting.
1. Domperidone selectively blocks levodopa-induced vomiting by acting on peripheral dopamine receptors in the chemoreceptor trigger zone.
2. It does not cross the blood-brain barrier, hence does not interfere with levodopa's antiparkinsonian action.
3. Metoclopramide (A) can cross the blood-brain barrier and may diminish the therapeutic effects of levodopa.
4. Cisapride (B) is a prokinetic agent and does not have a specific antiemetic effect on levodopa-induced vomiting.
5. Ondansetron (D) is a serotonin receptor antagonist that targets different pathways and does not specifically address levodopa-induced vomiting.